Background: A multidisciplinary, centralized referral program was established at our institution in 2014 to reduce delays in lung cancer diagnosis and treatment following diagnostic imaging observed with the traditional, primary care providereled referral process. The main objectives of this retrospective cohort study were to determine if referral to a Thoracic Triage Panel (TTP): 1) expedites lung cancer diagnosis and treatment initiation; and 2) leads to more appropriate specialist consultation. Methods: Patients with a diagnosis of lung cancer and initial diagnostic imaging between March 1, 2015, and February 29, 2016, at a Memorial Universityeaffiliated tertiary care centre in St John's, Newfoundland, were identified and grouped according to whether they were referred to the TTP or managed through a traditional referral process. Wait times (in days) from first abnormal imaging to biopsy and treatment initiation were recorded. Statistical analysis was performed using the Wilcoxon rank-sum test. Results: A total of 133 patients who met inclusion criteria were identified. Seventy-nine patients were referred to the TTP and 54 were managed by traditional means. There was a statistically significant reduction in median wait times for patients referred to the TTP. Wait time from first abnormal imaging to biopsy decreased from 61.5 to 36.0 days (P < .0001). Wait time from first abnormal imaging to treatment initiation decreased from 118.0 to 80.0 days (P < .001). The percentage of specialist consultations that led to treatment was also greater for patients referred to the TTP. Conclusions: A collaborative, centralized intake and referral program helps to reduce wait time for diagnosis and treatment of lung cancer.
The pathway for diagnosis of a suspected lung cancer is complex and wait times for individual diagnostic procedures and specialist appointments can be lengthy. Minimizing wait times reduces patients' emotional distress as well as health care costs incurred in the work-up period [1, 2] . Furthermore, mortality is highly dependent on disease stage, with 5-year survival rates plummeting from 49% in stage IA to 1% in stage IV non-small cell lung cancer [3] . Studies investigating the effect of timely care suggest reducing wait time for diagnosis and treatment of lung cancer may help to improve outcomes [4] .
A clinical audit of diagnostic imaging wait times in the diagnosis of lung cancer performed at our institution in 2009 demonstrated that prolonged wait times for computed tomography (CT)eguided biopsy resulted in tumour upstaging at time of diagnosis [5] . The hiring of additional CT technologists and extension of CT operating hours resulted in shorter wait times and less upstaging from first abnormal imaging to follow-up CT. However, these interventions had no significant impact on wait time and upstaging from follow-up CT to CT-guided biopsy, which continued to be delayed by inefficiencies including inappropriate specialist referrals. These delays necessitated further intervention to facilitate early collaboration and consensus of specialists in lung cancer care.
A Thoracic Triage Panel (TTP) was established at our institution in 2014 to reduce wait time and improve patient flow through lung cancer diagnosis and treatment. The key components of this centralized referral program include nurse navigation, weekly multidisciplinary meetings, and regular communication with the primary care provider (PCP). The nurse navigator coordinates patient care and acts as the contact person for patients and clinicians involved in the program. A working group of thoracic specialists including radiology, respirology, medical and radiation oncology, thoracic surgery, and pathology meets weekly to review new and ongoing cases, to determine optimal course for diagnosis and treatment, and to coordinate appropriate investigations and referrals. Communication with the PCP occurs via standardized forms at time of referral, initial review by the TTP, and discharge from the program.
The main objectives of this study are to determine if the TTP reduces wait time for lung cancer diagnosis and treatment and leads to more appropriate specialist consultation than the traditional, PCP-led referral process. Once validated, our multidisciplinary, centralized referral model may be adopted by other institutions across the country as an adjunct to primary and secondary prevention strategies aimed at reducing the burden of lung cancer in Canada [6] .
Methods

Design and Setting
A retrospective cohort study was conducted at the Health Sciences Centre (including the Dr H. Bliss Murphy Cancer Centre) and St Clare's Mercy Hospital, both Memorial Universityeaffiliated tertiary care centres located in St John's, Newfoundland.
Study Population
Adult patients of any age and sex with a plain film or CT study reported as concerning for lung cancer between March 1, 2015, and February 29, 2016, and a pathological diagnosis of primary lung cancer were included. All lung cancer subtypes including small cell and non-small cell lung cancers were included.
Patients admitted to hospital for any duration of the workup or treatment of their lung cancer were excluded to avoid confounding from expedited inpatient investigations and referrals.
Full approval for this study was granted by the Human Research Ethics Board at Memorial University of Newfoundland before study initiation.
Thoracic Triage Panel
Referral to the TTP is initiated when a plain film or CT study reported as concerning for lung cancer is identified by the reporting radiologist and faxed to the TTP for review. The TTP then sends a referral form to the PCP (Supplemental Appendix S1). Completion and return of this form following acquisition of consent for referral to the TTP are required for successful entry into the program. Upon receipt of the completed referral form, a nurse navigator makes immediate telephone contact with the patient. Patients are reviewed by the TTP within 7 days of referral at weekly meetings. Following initial review, a follow-up form is sent to the PCP informing him or her of the investigations and specialist consults arranged (Supplemental Appendix S2). Finally, the TTP sends a summary to the PCP after final review and discharge from the program (Supplemental Appendix S3). The summary indicates whether a malignancy was confirmed or not. In the case of a confirmed malignancy, the appropriate specialist referral for treatment planning is specified. In the case of no confirmed malignancy, instructions for follow-up imaging are included when appropriate. If follow-up imaging is abnormal, the patient may be referred back to the TTP.
Data Collection
Patients who met inclusion criteria were identified through the Dr H. Bliss Murphy Cancer Centre Registry. Patients were grouped into 2 cohortsdthose referred to the TTP and identified in the TTP Patient Registry and those managed via the traditional, PCP-led referral process and identified in the Cancer Centre Registry alone.
Patient characteristics and relevant dates were abstracted from our institution's electronic medical record. The dates collected included: 1) date of first abnormal imaging, which was defined as the date of the first study, commonly a plain film or CT, that raised suspicion for lung cancer; 2) date of initial review by the TTP, which was defined as the date of the meeting at which the patient was first discussed by the TTP (when applicable); 3) date of biopsy, which was defined as the date of the biopsy, commonly a CT-guided, transbronchial, or surgical lung biopsy, that yielded the pathological diagnosis of lung cancer; and 4) date of treatment initiation, which was defined as the date of first thoracic surgery or the first day of chemotherapy or radiation, whichever came first.
Wait times were calculated as the number of calendar days between dates. Analyses of wait times included only cases in which the event or intervention was applicable and a corresponding date could be found in the electronic medical record. March 1, 2015, was selected as the start date for the study as key program modifications were implemented by that date.
Statistical Analysis
The distribution of continuous characteristics was reported as mean AE standard deviation (SD) or median (interquartile range [IQR] ). Categorical variables were reported as numbers and percentages of the cohorts. The Wilcoxon rank-sum test was used to investigate the effect of the TTP on median wait times. We plotted a Kaplan-Meier curve for wait time from first abnormal imaging to treatment initiation for the 2 cohorts. The R statistical software package (R version 3.3.1; R Core Team, Vienna, Austria) was used for all statistical analysis and P < .05 was considered statistically significant.
Results
Patient Characteristics
A total of 133 patients identified in the Dr H. Bliss Murphy Cancer Centre Registry met inclusion and exclusion criteria (Table 1) . Seventy-nine patients were referred to the TTP and 54 were managed by traditional means. The mean age of patients referred to the TTP was 69.0 AE 7.9 years. The mean age of patients managed by traditional means was 71.6 AE 8.1 years. Thirty-seven patients (46.8%) referred to the TTP were women compared with 30 patients (55.6%) managed by traditional means.
Wait Times
Referral to the TTP was associated with a statistically significant decrease in median wait times for diagnosis and treatment (Table 2 ). Median wait time from first abnormal imaging to treatment initiation was 80.0 (IQR: 55.0e110.8) days for patients referred to the TTP compared with 118.0 (IQR: 70.5e186.0) days for patients managed by traditional means (P ¼ .00072). The effect of the TTP was mainly in reducing median wait time from first abnormal imaging to diagnostic biopsy, an interval of 36.0 (IQR: 21.0e49.0) days for patients referred to the TTP compared with 61.5 (IQR: 35.5e187.0) days for patients managed by traditional means (P ¼ .000076). Median wait time from biopsy to treatment initiation did not change significantly with TTP intervention.
The estimated probability of treatment initiation at any given time following first abnormal imaging in each cohort is illustrated in Figure 1 . All but 5 patients managed by traditional means experienced longer delay to treatment initiation than patients referred to the TTP. Of these patients, 3 were consulted to a TTP surgeon who determined they had inoperable, metastatic cancer and urgently referred them to the cancer clinic for palliative chemotherapy or radiation. One patient was referred to the cancer clinic by the PCP for palliative chemoradiation of bone metastases before biopsy of the primary lung cancer. One patient was expertly navigated through diagnosis and referral to the cancer clinic by an experienced PCP.
Appropriateness of Specialist Consultation
Appropriateness of specialist consultation was defined as the percentage of specialist consults including thoracic surgery, medical oncology, and radiation oncology that led to treatment by that specialty. Appropriateness of specialist consultation was greater for patients referred to the TTP than for those managed by traditional means (Table 3) . A total of 104 specialist consults (80.0%) arranged by the TTP resulted in treatment by that specialist compared with 62 specialist consults (64.6%) arranged by traditional means. This trend 
Discussion
Despite the increasing emphasis on timely delivery of cancer care in Canada, there are currently no evidence-based guidelines for wait time targets in lung cancer. While numerous studies report delays in diagnosis and treatment of lung cancer, conclusions regarding effect on patient outcomes are mixed and often paradoxical, preventing the development of evidence-based targets [4] . Furthermore, comparisons across studies are limited due to heterogeneity in study design and interval definition. However, multiple interventions aimed at improving timeliness of care for patients with suspected lung cancer have been evaluated [4] . Of these, nurse-led care coordination and rapid diagnostic algorithms appear to be most effective in reducing wait times [7e14] .
Studies evaluating the role of nurse navigators in the assessment and restructuring of 2 European lung cancer services have shown significant reductions in delays to diagnosis and treatment. Leary and Corrigan [7] reported a reduction from 38 to 8 days of mean wait time from decision to treat to treatment initiation following a nurse-led intervention at a tertiary care centre in the United Kingdom. This nurse-led intervention included a comprehensive audit of local services, a restructuring of referral processes, and hospital-wide educational initiatives. Holgersson et al [8] described similar success in reducing median wait time from suspicion of lung cancer to treatment initiation from 71 to 45 days following the implementation of patient guides at hospitals across central Sweden.
Two studies reported significant reductions in wait time for treatment initiation using ''two-stop'' diagnostic pathways in which patients with suspected lung cancer received a staging CT, biopsy, and other diagnostic tests at their initial visit and a treatment plan was developed by a multidisciplinary team within 3 days [9, 10] . Laroche et al [9] reported a 50% decrease in median wait time from first specialist appointment to surgical resection in 275 patients referred to a single tertiary care centre in the United Kingdom following implementation of this ''two-stop'' diagnostic process. A subsequent randomized pilot study by Murray et al [10] demonstrated a 4-week reduction in median wait time from Figure 1 . Estimated probability of treatment initiation vs time. This figure is available in colour online at http://carjonline.org/. first presentation to treatment initiation for patients randomized to the ''two-stop'' arm. A retrospective cohort study by Brocken et al [11] demonstrated the efficacy of a similar rapid outpatient diagnostic program (RODP) at a university hospital in the Netherlands. Outpatients referred to the RODP with radiological suspicion of lung cancer received a full diagnostic workup including 18 fluorodeoxyglucose positron emission and contrast enhanced CT scan within 2 days. This program achieved a median diagnostic delay of 2 (IQR: 1e17.5) days and a median wait time from first RODP day to treatment initiation of 25 (IQR: 18-39) days. For comparison, median wait time from initial review by the TTP to treatment initiation at our institution was 56 (IQR: 36.2e86) days. However, these rapid diagnostic algorithms impose limitations on the number of patients that can begin diagnostic work-up each weekd4 per week in the RODP reported by Brocken et al [11] and 9 per week in the ''two-stop'' process described by Laroche et al [9] . By contrast, the TTP at our institution aims to discuss all new patients at a multidisciplinary meeting within 7 calendar days of referral and diagnostic work-up begins immediately.
A clinical audit of diagnostic imaging wait times performed at our institution revealed that CT-guided biopsy of suspected lung cancers was delayed by numerous specialist referrals and inconclusive biopsy attempts and this contributed to stage migration [5] . Sequential specialist referrals following diagnosis were also perceived as contributing to delay of treatment initiation. To reduce delay and to improve patient flow through diagnosis and treatment of lung cancer, our institution implemented a centralized, multidisciplinary referral program, which includes: 1) nurse-led care coordination; 2) patient referral triggered by imaging suggesting a new diagnosis of lung cancer; and 3) weekly, multidisciplinary meetings at which collaborative diagnostic and treatment planning takes place. The main effect of our program was to reduce median wait time from first abnormal imaging to treatment initiation from 118 to 80 days. Most of this effect was seen in time from first abnormal imaging to diagnosis, which decreased from 61.5 to 36 days. There was no significant improvement in time from diagnosis to treatment initiation. Our program also increased appropriateness of specialist consultation from 64.6% to 80%.
The strengths of our program include nurse-led care coordination, early specialist consensus, and ongoing communication with the PCP. In our program, patients are discussed at weekly, multidisciplinary meetings and the appropriate investigations and specialist referrals are arranged before the patients meet face to face with a specialist. As such, the nurse navigators play an important role in developing personal relationships with patients and in communicating the plans developed by the thoracic specialists at weekly meetings. Unlike traditional tumour boards that meet to discuss treatment options following diagnosis, our panel discusses patients with radiological suspicion of lung cancer and, in most cases, very little additional diagnostic workup. While most patients undergo a CT study before TTP referral, our program also encourages referral of patients with obvious plain film findings in the right clinical context. Early referral to the TTP enables specialist consensus on diagnostic approach, which helps to reduce inappropriate investigations and specialist referrals and thus diagnostic delay. Importantly, sensitivity of radiologist-led referral to the TTP remains high with 87.8% of referred patients diagnosed with primary lung cancer. Involvement of multiple specialists in diagnostic decisions also minimizes delay due to individual specialist circumstances (eg, holidays, long wait lists). Finally, our program encourages continuity of care through the PCP. By providing the PCP with updates on his or her patient's progress following weekly meetings, our program ensures that patients receive the counselling and support that they require from the physician who knows them best.
Our program shares many features with 2 other rapid outpatient diagnostic programs reported in the literature [12e14] . A retrospective cohort study by Alsamarai et al [12] demonstrated significant improvement in wait times for diagnosis and treatment of non-small cell lung cancer following implementation of a Cancer Care Coordination Program (CCCP) at a Veterans Affairs hospital in the United States [13] . The CCCP shares many common features with the TTP program at our institution, including nurse-led care coordination, a centralized process of flagging abnormal chest imaging, and weekly, multidisciplinary meetings at which diagnostic and staging plans are developed. Implementation of the CCCP resulted in a 25-day reduction in mean wait time from first abnormal imaging to treatment initiation (126 days [before] vs 101 days [after] ). This reduction in overall wait time was predominantly due to a 23-day reduction in mean wait time from first abnormal imaging to diagnosis (76 days [before] vs 53 days [after]). As in our study, wait time from diagnosis to treatment initiation did not change significantly postimplementation of the CCCP.
The Time to Treat Program for rapid diagnostic workup of outpatients with imaging suggesting a new diagnosis of lung malignancy at a community hospital in Toronto was described by Lo et al [14] . This program, which also relied on nurse-led care coordination and weekly, multidisciplinary meetings, effectively reduced median wait time from first abnormal imaging to diagnosis from 128 to 20 days. However, patients were initially referred to a respirologist or thoracic surgeon who arranged the appropriate investigations and referrals to other subspecialty services required for diagnosis. At our institution, patients are discussed by a panel of thoracic specialists and all appropriate investigations are arranged before the first specialist appointment. In this way, our program achieves early specialist consensus, productive specialist consultation, and reduced burden of specialist appointments on patients.
Limitations
This study has certain limitations. First, our data is retrospective and has all the inherent limitations of this design. These include reliance on medical records and, thus, incomplete data. Fortunately, the electronic medical record has reduced the incidence of incomplete patient datasets at our institution. Second, this study was conducted at 2 university-affiliated tertiary care centres in a single Canadian city and may be affected by referral bias. Further studies are required to determine if this model can be applied with similar benefits at other tertiary centres across the country and in rural settings where access to tertiary care may be limited. Furthermore, while early referral of patients with obvious plain film findings is feasible in smaller tertiary care centres, this may not be feasible in larger centres across Canada due to patient volume. Another consideration is the contribution of voluntary delays to wait time. While wait time is predominantly involuntary due to limited hospital resources and long wait lists, patients may choose to delay or miss appointments for personal reasons including vacation, transportation, and anxiety regarding the new diagnosis of lung cancer. In this study, we did not differentiate between voluntary and involuntary delays. Finally, although our study has demonstrated decreased wait times for diagnosis and treatment of lung cancer, whether this trend translates into improved patient outcomes remains to be seen. On the other hand, the value of shorter diagnostic delays in reducing emotional distress in patients with suspected malignancies is well established [1] .
Conclusions
In summary, our data show that early referral of patients with imaging, suggesting that a new diagnosis of malignancy to a TTP is associated with reduced wait time and with more appropriate specialist consultation in the diagnosis and treatment of lung cancer. This is the first study to demonstrate the validity of a centralized, multidisciplinary referral program in achieving timely delivery of lung cancer care in a publicly funded health care system. Similar programs may be adopted by other institutions across the country as an adjunct to primary and secondary prevention strategies aimed at reducing the burden of lung cancer in Canada. This model may also be valuable in the work-up of other malignancies that require the coordination and collaboration of multiple specialties for diagnosis and treatment planning.
